South 8 Technologies, a San Diego–based innovator redefining lithium-ion battery performance with its patented LiGas® cell technology, today announced it has signed a Letter of Intent (LOI) with Galvion, a global leader in the design and manufacture of intelligent power and data management solutions, innovative head systems and integrated soldier systems. The LOI represents a shared commitment between two innovative defense and energy organizations to push the boundaries of battery performance through focused research and product development.

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease and cancer, and ImmunoScape, Pte. Ltd, a biotechnology company developing next-generation T cell receptor (TCR)-based therapies in oncology, today announced that they have entered into a collaboration and license agreement to advance a novel in vivo approach to cell therapy for the treatment of solid tumors. Under the agreement, ImmunoScape will develop a novel Seed-and-Boost immunotherapy that combines Cue Biopharma’s clinically-validated Immuno-STAT T-cell engagers, the CUE-100 series, with ImmunoScape’s proprietary TCRs. The combination therapy is designed to overcome core limitations of existing cell therapies with the potential for establishing a breakthrough standard of care with superior anti-tumor activity, durable T cell persistence and product scalability.

Niron Magnetics, the company manufacturing high-performance Iron Nitride permanent magnets made without rare earths, announced an expanded partnership with the City of Sartell to build the company’s first full-scale production facility. This collaboration builds on prior agreements, including the purchase of 79 acres of land in Sartell’s Mill District, and marks a major step in Niron Magnetics’ expansion and the community’s economic development.

AM Batteries (AMB) demonstrated commercial-scale dry electrode manufacturing using its proprietary dry deposition method to over 70 industry leaders during Demo Day, proving the technology delivers the cost savings and performance needed to accelerate EV adoption and strengthen domestic battery manufacturing.

Thirdwayv Inc., a leader in secure software solutions for connected medical devices, and Medcrypt Inc., a premier provider of medical device cybersecurity and vulnerability management solutions, announced today at the Diabetes Technology Society Conference, DTM 2025, the signing of an agreement to jointly advance cybersecurity and interoperability standards and solutions across the connected medical device ecosystem.

South 8 Technologies, a San Diego-based innovator redefining lithium-ion battery performance with its patented LiGas® technology, today announced it has signed a Letter of Intent (LOI) with CTNS, a pioneering battery solutions provider from South Korea with North American operations in Redmond, Washington. The LOI establishes a framework for strategic collaboration between the companies and identifies initial joint customers.